An observational study in Altered Mental Status, Sepsis and Heart Failure, sponsored by Zoll Medical Corporation. Enrolling by invitation at 5 sites in United States. Per ClinicalTrials.gov, last updated 2026-09-01.
Sponsored by Zoll Medical Corporation · Observational
This study will collect and characterize ventilator use during patient care with a ZOLL 731 Series ventilator in a pre-hospital setting.
This is a prospective, observational study.
ZOLL will develop a methodology to collect and transfer ventilator data from the device to ZOLL to allow for a characterization of ventilator use in the pre-hospital setting. This knowledge and experience will subsequently be used to inform development of a mechanism to allow for automatic data collection and transmission from ZOLL ventilators to a central data repository. These data will be used to provide feedback, reporting, and benchmarking to individual agencies and departments on their ventilator use as well as aggregate use data from all ventilators to allow for comparisons.
Enrollment in this study is expected to take approximately 24 months. No patient outcome data will be collected.Participants are enrolled once data have been downloaded from the ventilator via RescueNet® VentReview software. Participants will not be followed after the assessment of study objectives.
2,416 studies on the registry are indexed under Sepsis; 541 are open to participants now.
This study's planned enrollment of 500 is above the median of 150 across 1,162 observational studies indexed under Sepsis.
Browse Sepsis studies →Zoll Medical Corporation is the lead sponsor of 36 studies on the registry; 6 are open to participants now.
Counted across the registry records on this site, refreshed daily.
Cases where participating EMS Agencies use ZOLL 731 Series ventilator in accordance with device labeling and Agency protocols in a pre-hospital setting
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Candidates for this study must meet all of the following Inclusion criteria:
Exclusion Criteria:
Patients being ventilated by the ZOLL 731 Series ventilator in accordance with device labeling and Agency protocols in a pre-hospital setting.
Device: 731 Series Ventilator
FDA cleared ventilator indicated for use in the management of acute or chronic respiratory failure or during resuscitation.
Ventilator modes used
Characterizing how often ventilator modes are used during mechanical ventilation
Time frame: Through study completion, an average 1 hour
Ventilator settings used
Characterizing how often ventilator settings are changed during mechanical ventilation
Time frame: Through study completion, an average 1 hour
Ventilator Alarm type
Characterize type of alarms triggered during mechanical ventilation
Time frame: Through study completion, an average 1 hour
Ventilator Alarm Frequency
Characterize frequency of alarms triggered during mechanical ventilation
Time frame: Through study completion, an average 1 hour
Plan to share: No
No publications or documents are linked to this record.
Started Jun 2022 (actual). Primary completion is estimated for Apr 2030, 94 months after the start.
Of 52 industry-sponsored observational studies under Sepsis, half reached primary completion within 16 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 44. This study's planned 94 months is above that.
Counting every sponsor, half of 543 studies reached it within 27 months; a quarter within 12 and three quarters within 56.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
No contact was published for this record. The registry link below has the sponsor’s details.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.